Turning a page in drug control and public health: advancing HCV/HIV prevention through reform of drug law and policy

2015 ◽  
Vol 10 (1) ◽  
pp. 17-26
Author(s):  
Joanne Csete ◽  
Daniel Wolfe
2017 ◽  
Vol 47 (3) ◽  
pp. 396-404 ◽  
Author(s):  
Konstantinos Alexandris Polomarkakis

From the closure of London’s nightclub Fabric to Duterte’s drug war, law enforcement has become the policy choice par excellence for drug control by stakeholders around the globe, creating a rift between theory and practice, the former vehemently dismissing most of its alleged benefits. This article provides a fresh look on the said regime, through examining its implications in the key areas of illicit drug markets, public health, and broader society. Instead of adopting a critical stance from the start, as much of the literature does, the issue is evaluated from the perspective of a focus on the logic and rationality of drug law enforcement approaches, to showcase from within how problematic the latter are. The article concludes by suggesting at least a reconceptualization of the concept, to give way to more sophisticated policies for finally tackling the issue of illegal drugs effectively.


2002 ◽  
Vol 32 (2) ◽  
pp. 363-378 ◽  
Author(s):  
Lorenz Böllinger

Drug use and drug control are theoretically — in terms of both social psychology and sociology — viewed as complementary components of a complex social and historical interaction process. Subsequently historical and other evidence is presented to substantiate the theoretical hypotheses. This lays the ground for the presentation and interpretation of the actual drug control system in Germany and the European Union. Again some theoretical hypotheses and their empirical grounding are presented concerning the logic of development trends. In the final part, the evolution of drug laws and their implementation are viewed. Recent developments can be regarded as taking place in stages based on certain changeable paradigms: the abstinence paradigm, the medicalization paradigm and the acceptance paradigm. For the time being there seems to be a slow transition from the first to the latter, implying that elements of all three are presently active in a diversity of policies and strategies, differing between states and regions of the German federal state and the European Union as well as between different levels of drug policy and drug care.


1999 ◽  
Vol 41 (2) ◽  
pp. 275-284 ◽  
Author(s):  
Patricia G. Erickson
Keyword(s):  

2021 ◽  
Vol 55 (2) ◽  
pp. 395-418
Author(s):  
Akwasi Owusu-Bempah

Canada has received praise and international attention for its departure from strict cannabis prohibition and the introduction of a legal regulatory framework for adult use. In addition to the perceived public health and public safety benefits associated with legalization, reducing the burden placed on the individuals criminalized for cannabis use served as an impetus for change. In comparison to many jurisdictions in the United States, however, Canadian legalization efforts have done less to address the harms that drug law enforcement has inflicted on individuals and communities. This article documents the racialized nature of drug prohibition in Canada and the US and compares the stated aims of legalization in in both jurisdictions. The article outlines the various reparative measures being proposed and implemented in America and contrasts those with the situation in Canada, arguing, furthermore that the absence of social justice measures in Canadian legalization is an extension of the systemic racism perpetuated under prohibition.


Author(s):  
Anaïs Bertrand-Dansereau

In Malawi, as elsewhere in southern Africa, faith-based organisations (FBOs) have been integrated in the official response to HIV/AIDS. This new role, and the funding that accompanies it, has professionalised their traditional care activities around AIDS patients, widows and orphans, and it has also put them in charge of HIV prevention. As HIV preventers, they are asked to bridge epistemic differences between conflicting notions of sexuality and morality by reconciling public health messages, Christian teachings and local cosmologies. This becomes challenging when it comes to the question of sexuality education, specifically the promotion of abstinence, and condom use. Many FBO leaders’ response to this challenge is nuanced and defies stereotypes, as they try to balance their concern for young people, the demands of donors and the moral imperatives of their faith.


2019 ◽  
pp. 52-91 ◽  
Author(s):  
Anniek de Ruijter

Taking into consideration the central health provision in the Treaty, which outlines that health is to be ‘mainstreamed’ in all other EU policies, it could be inferred that EU public health and health-care policy and law is either non-existent as an autonomous policy area, or that it is basically everything, in that all EU public policy is also health policy. This puzzle forms the starting point for this chapter, which describes the nature of EU power in the field of human health currently. The chapter first, as an initial exploration, questions the existence of a European authoritative concept of ‘health’. Second, the chapter takes into consideration the nature of EU policymaking in general and regarding health in particular and develops a concept of EU health law and policy, distinguishing between EU public health and EU health-care law and policy. Last, to draw out the scope of EU health policy more specifically, a historical overview is given of the involvement of the EU in health. The chapter conceptualizes EU power in the field of human health as authoritative allocations of value through the European Union political system with the object of protecting and promoting human health. This conceptualization draws out the scope of policy that will be the central focus for the following chapters.


2020 ◽  
Vol 30 (1) ◽  
pp. 25-36
Author(s):  
MICHAEL DA SILVA

AbstractCOVID-19-related controversies concerning the allocation of scarce resources, travel restrictions, and physical distancing norms each raise a foundational question: How should authority, and thus responsibility, over healthcare and public health law and policy be allocated? Each controversy raises principles that support claims by traditional wielders of authority in “federal” countries, like federal and state governments, and less traditional entities, like cities and sub-state nations. No existing principle divides “healthcare and public law and policy” into units that can be allocated in intuitively compelling ways. This leads to puzzles concerning (a) the principles for justifiably allocating “powers” in these domains and (b) whether and how they change during “emergencies.” This work motivates the puzzles, explains why resolving them should be part of long-term responses to COVID-19, and outlines some initial COVID-19-related findings that shed light on justifiable authority allocation, emergencies, emergency powers, and the relationships between them.


Sign in / Sign up

Export Citation Format

Share Document